Xterna

Xterna is a biotechnology company developing cell-specific molecular binders composed of xeno nucleic acids (XNAs), chemically modified nucleic acids distinct from naturally occurring DNA and RNA.

XNA-based binders are engineered to target cell types that evade conventional antibody-based approaches, enabling drug delivery to previously inaccessible tissues.

The platform is designed to carry nucleic acid therapeutic payloads, improving delivery precision and reducing off-target effects.